Mylan’s Glove-Integrity Warning Letter Fix Didn’t Extend to Adjacent Site
This article was originally published in The Gold Sheet
It’s a constant challenge for pharmaceutical manufacturers to ensure that quality problems identified at one site are fixed globally. In Mylan’s case, a problem with holes in gloves was resolved at one sterile manufacturing facility, but continued at another – even though it was right next door.
Register for our free email digests: